SPOP-IN-6lc

CAS No. 2136270-56-7

SPOP-IN-6lc( —— )

Catalog No. M36313 CAS No. 2136270-56-7

SPOP-IN-6lc is a potent SPOP inhibitor with multiple roles in cancer, oncostatic in a variety of tumors, but functions as an oncogene in renal cancer.SPOP-IN-6lc can be used to study cell signaling and apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 233 In Stock
5MG 366 In Stock
10MG 587 In Stock
25MG 1067 In Stock
50MG 1435 In Stock
100MG 1881 In Stock
500MG 3807 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SPOP-IN-6lc
  • Note
    Research use only, not for human use.
  • Brief Description
    SPOP-IN-6lc is a potent SPOP inhibitor with multiple roles in cancer, oncostatic in a variety of tumors, but functions as an oncogene in renal cancer.SPOP-IN-6lc can be used to study cell signaling and apoptosis.
  • Description
    SPOP-IN-1 is a selective SPOP E3 ubiquitin ligase inhibitor. SPOP-IN-1 leads to the accumulation of tumor suppressors PTEN and DUSP7 and decreased levels of phosphorylated AKT and ERK in clear-cell renal cell carcinoma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2136270-56-7
  • Formula Weight
    505.64
  • Molecular Formula
    C26H31N7O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC1=CC=CS1)N2C3=C(C(=O)N4C(=N3)C(C)=CC=C4)C=C(C(NCCN5CCN(C)CC5)=O)C2=N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dong Z, et al. Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer. J Med Chem. 2020 May 14;63(9):4849-4866. ?
molnova catalog
related products
  • Cipepofol

    Cipepofol (HSK3486) is a GABAA receptor agonist with sedative properties and protective effects in a variety of cardiovascular diseases.

  • 3BDO

    3BDO is a new mTOR activator. 3BDO inhibits autophagy.

  • Manganese chloride

    Manganese chloride inhibits proliferation in a dose- and time-dependent manner induces G0/G1 and S phase arrest and apoptosis in A549 cells.